Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer
PHASE2
Lung cancer is one of the malignant tumors with high morbidity and mortalit...
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
PHASE2
This is a Phase II, randomized, open-label, active-controlled, multicenter ...
A Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC
PHASE2
This clinical trial aims to evaluate the efficacy and safety of neoadjuvant...
Status
Not Yet Recruiting
Location
Affiliated Cancer Hospital and Institute of Guangzhou Medical Univercity